Showing results (191-200 of 465) with videos related to
Sort By:
Pageof 47
Neurotoxicology|January 23, 2025
In silico and In vivo protective effect of biochanin-A mitigating doxorubicin- induced cognitive deficits and neuroinflammation: Insights to the role of p-Tau and miR-132Sarah A Hussein, Mai F Tolba, Haidy E Michel, et al.Microbial Pathogenesis|December 25, 2019
Antitumor effect of exopolysaccharide produced by Bacillus mycoidesMohamed M S Farag, Saad A M Moghannem, Amr M Shehabeldine, et al.Inflammopharmacology|August 3, 2022
Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signalingMennatallah O Zaki, S El-Desouky, Doaa A Elsherbiny, et al.Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|February 17, 2018
Exopolysaccharide production from Bacillus velezensis KY471306 using statistical experimental designSaad A M Moghannem, Mohamed M S Farag, Amr M Shehab, et al.Neurochemistry International|June 2, 2020
Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarksSara A Wahdan, Marwa O El-Derany, Amany E Abdel-Maged, et al.Psychopharmacology|January 14, 2025
Captopril attenuates oxidative stress and neuroinflammation implicated in cisplatin-induced cognitive deficits in ratsFatma Mostafa, Eman M Mantawy, Riham S Said, et al.International Journal of Molecular Sciences|January 19, 2020
Potential Therapeutic Strategies for Lung and Breast Cancers through Understanding the Anti-Angiogenesis Resistance MechanismsWafaa S Ramadan, Dana M Zaher, Alaa M Altaie, et al.Human Immunology|December 31, 2018
Interleukin-6 promotor gene polymorphisms and susceptibility to chronic hepatitis B virus in EgyptiansEman A El-Maadawy, Roba M Talaat, Maha M Ahmed, et al.International Immunopharmacology|May 1, 2007
Chemically-modified polysaccharide extract derived from Leucaena leucocephala alters Raw 264.7 murine macrophage functionsAmira M Gamal-Eldeen, Hassan Amer, Wafaa A Helmy, et al.Frontiers in Pharmacology|May 18, 2026
Common oncogenic mutations in colorectal cancer: drivers of carcinogenesis and potential therapeutic targetsAbaher O ALTamimi, Noha M Elemam, Shirin Hafezi, et al.Pageof 47